NanoGroup S.A. (WSE:NNG)
Poland · Delayed Price · Currency is PLN 2.350
0.00 (0.00%)
Oct 30, 2026, 4:49 PM CET
NanoGroup Revenue
Revenue (ttm)
2.37M
Revenue Growth
n/a
P/S Ratio
42.25
Revenue / Employee
n/a
Employees
n/a
Market Cap
100.18M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 2.10K | 81.00 | 4.01% |
| Dec 31, 2023 | 2.02K | -137.53K | -98.55% |
| Dec 31, 2022 | 139.55K | -352.94K | -71.66% |
| Dec 31, 2021 | 492.49K | -195.02K | -28.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 257.23M |
| Ryvu Therapeutics | 83.94M |
| Synthaverse | 48.76M |
| Mabion | 17.61M |
| Read-Gene | 16.66M |
| Molecure | 6.52M |
| Urteste | 2.77M |
| Captor Therapeutics Spolka Akcyjna | 2.01M |